Skip to content

ERNA

Ernexa Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.98
−5.26%
Ask drillr

Margins

Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-383.0%
Return on equity
-194.1%
Return on assets
-330.7%
Return on invested capital
0.00x
Asset turnover
-$8.8M
Cash from operations
$3.08
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026